The cost impact of unselective vs selective MammaPrint testing in early-stage breast cancer in Southern Africa.

Background: MammaPrint (MP) has been applied in South Africa (SA) for decision-making in early-stage hormone receptor-positive breast cancer since 2006. The cost-impact of MP in SA has not been assessed.

Aim: To assess different MP testing strategies for cost-minimization in early-stage breast carcinoma using a funder perspective.

1-[(1-Methyl-1H-imidazol-5-yl)meth-yl]-1H-indole-5-carbonitrile.

In the title compound, C14H12N4, the dihedral angle between the indole ring system (r.m.s.